Allogene Therapeutics
ALLO
ALLO
170 hedge funds and large institutions have $301M invested in Allogene Therapeutics in 2025 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 64 increasing their positions, 42 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
2% less funds holding
Funds holding: 174 → 170 (-4)
10% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 30
25% less capital invested
Capital invested by funds: $402M → $301M (-$100M)
Holders
170
Holding in Top 10
6
Calls
$444K
Puts
$152K
Top Buyers
| 1 | +$19.7M | |
| 2 | +$10.1M | |
| 3 | +$9.15M | |
| 4 |
Goldman Sachs
New York
|
+$7.06M |
| 5 |
JP Morgan Chase
New York
|
+$2.64M |
Top Sellers
| 1 | -$30.9M | |
| 2 | -$8.41M | |
| 3 | -$3.19M | |
| 4 |
Two Sigma Investments
New York
|
-$1.2M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
-$986K |